Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Unity Biotechnology, Inc. Common Stock (UBX)

Pharmaceutical Preparations

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

285 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/03/2018

Market Cap

23,900,005

Shares Outstanding

16,790,000

Weighted SO

16,784,969

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

EXAI --.--%

RXRX --.--%

AVIR --.--%

ICVX --.--%

HOOK --.--%

ABOS --.--%

HRTX --.--%

FIXX --.--%

RNA --.--%

Beta

0.8390

Last Div

0.0000

Range

1.22-2.66

Chg

0.0086

Avg Vol

54240

Mkt Cap

23900005

Exch

NASDAQ

Country

US

Phone

650 416 1192

DCF Diff

1.9018

DCF

-0.4865

Div Yield

0.0000

P/S

12.5657

EV Multiple

-0.9398

P/FV

1.2076

Div Yield %

0.0000

P/E

-0.7771

PEG

-0.0140

Payout

0.0000

Current Ratio

4.0651

Quick Ratio

4.0651

Cash Ratio

0.8601

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

538.4397

CCC

-538.4397

Gross Margin

0.4811

Op Margin

-21.6015

Pretax Margin

-16.1393

Net Margin

-16.1393

Eff Tax Rate

0.0632

ROA

-0.5735

ROE

-1.1333

ROCE

-0.9191

NI/EBT

1.0000

EBT/EBIT

0.7471

EBIT/Rev

-21.6015

Debt Ratio

0.4047

D/E

1.0964

LT Debt/Cap

0.5230

Total Debt/Cap

0.5230

Int Coverage

87.6034

CF/Debt

-1.1291

Equity Multi

2.7094

Rec Turnover

0.0000

Pay Turnover

0.6779

Inv Turnover

0.0000

FA Turnover

0.1151

Asset Turnover

0.0355

OCF/Share

-1.4544

FCF/Share

-1.4550

Cash/Share

2.0210

OCF/Sales

-12.8580

FCF/OCF

1.0004

CF Coverage

-1.1291

ST Coverage

0.0000

CapEx Coverage

-2223.2727

Div&CapEx Cov

-2223.2727

P/BV

1.2076

P/B

1.2076

P/S

12.5657

P/E

-0.7771

P/FCF

-0.9768

P/OCF

-0.9754

P/CF

-0.9754

PEG

-0.0140

P/S

12.5657

EV Multiple

-0.9398

P/FV

1.2076

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 25, 20:30 U-BX Technology Ltd. Announced Receipt of Notification Letter from Nasdaq Benzinga Nov 16, 14:41 Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution Benzinga Nov 16, 14:41 Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution

Revenue Product Segmentation